TY  - JOUR
AU  - Elgendy, Islam Y.
AU  - Capodanno, Davide
PY  - 2017
TI  - Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?
JF  - Journal of Thoracic Disease; Vol 9, No 11 (November 29, 2017): Journal of Thoracic Disease (Quantitative Imaging of Thoracic Diseases)
Y2  - 2017
KW  - 
N2  - Percutaneous coronary intervention (PCI) is the cornerstone of management for patients with ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) (1-6). Anticoagulation is routinely administered during PCI in order to minimize the risk of thrombotic events. However, the choice of anticoagulation should be balanced with the risk of bleeding.
UR  - https://jtd.amegroups.org/article/view/16836